BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 10102630)

  • 1. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
    Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
    Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
    Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
    EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SPI-1 transforming properties depend upon specifically activated forms of the EPOR.
    Pereira R; Raingeaud J; Pironin M; Ghysdael J; Quang CT
    Oncogene; 2000 Oct; 19(44):5106-10. PubMed ID: 11042699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
    Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
    Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
    Wong KS; Li YJ; Howard J; Ben-David Y
    Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Up-regulation of SLAP in FLI-1-transformed erythroblasts interferes with EpoR signaling.
    Lebigot I; Gardellin P; Lefebvre L; Beug H; Ghysdael J; Quang CT
    Blood; 2003 Dec; 102(13):4555-62. PubMed ID: 12946994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spi-1/PU.1 is a positive regulator of the Fli-1 gene involved in inhibition of erythroid differentiation in friend erythroleukemic cell lines.
    Starck J; Doubeikovski A; Sarrazin S; Gonnet C; Rao G; Skoultchi A; Godet J; Dusanter-Fourt I; Morle F
    Mol Cell Biol; 1999 Jan; 19(1):121-35. PubMed ID: 9858537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spi-1 and mutant p53 regulate different aspects of the proliferation and differentiation control of primary erythroid progenitors.
    Quang CT; Pironin M; von Lindern M; Beug H; Ghysdael J
    Oncogene; 1995 Oct; 11(7):1229-39. PubMed ID: 7478542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of the Spi-1/PU.1 oncogene induces the expression of TRIM10/HERF1, a key factor required for terminal erythroid cell differentiation and survival.
    Blaybel R; Théoleyre O; Douablin A; Baklouti F
    Cell Res; 2008 Aug; 18(8):834-45. PubMed ID: 18560381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
    Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
    Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ets and retroviruses - transduction and activation of members of the Ets oncogene family in viral oncogenesis.
    Blair DG; Athanasiou M
    Oncogene; 2000 Dec; 19(55):6472-81. PubMed ID: 11175363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of the DNA-binding and transcriptional activation functions of human Fli-1 protein.
    Rao VN; Ohno T; Prasad DD; Bhattacharya G; Reddy ES
    Oncogene; 1993 Aug; 8(8):2167-73. PubMed ID: 8336942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation.
    Tamir A; Howard J; Higgins RR; Li YJ; Berger L; Zacksenhaus E; Reis M; Ben-David Y
    Mol Cell Biol; 1999 Jun; 19(6):4452-64. PubMed ID: 10330185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuous Fli-1 expression plays an essential role in the proliferation and survival of F-MuLV-induced erythroleukemia and human erythroleukemia.
    Cui JW; Vecchiarelli-Federico LM; Li YJ; Wang GJ; Ben-David Y
    Leukemia; 2009 Jul; 23(7):1311-9. PubMed ID: 19282832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
    Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
    Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtle distinct regulations of late erythroid molecular events by PI3K/AKT-mediated activation of Spi-1/PU.1 oncogene autoregulation loop.
    Breig O; Théoleyre O; Douablin A; Baklouti F
    Oncogene; 2010 May; 29(19):2807-16. PubMed ID: 20190819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.